NCL has launched Fraud.org/FakeRx, a new digital consumer education campaign to address the growing global crisis of harmful counterfeit medications. The World Health Organization estimates that one in every 10 medical products circulating in developed countries is either substandard or fake, and nearly $83 billion in counterfeit drugs are sold annually.
News you can use: health & drug safety updates
December 5, 2019
National Consumers League (NCL) announces new action center to help patients steer clear of deadly counterfeit drug websites
November 25, 2019
One in eight adults with heart disease delays filling a prescription, takes less of the medicaiton than prescribed or skips medications altogether due to high out-of-pocket costs, according to a study published in Circulation.
November 4, 2019
DEA and partners collect thousands of pounds of unwanted medications and vaping products during the 18th National Prescription Drug Take Back Day
Americans nationwide have once again shown their strong support for DEA’s National Prescription Drug Take Back Day by dropping off nearly 883,000 pounds of medications during the October 2019 Take Back event.
November 4, 2019
One in five older adults said that they've taken leftover antibiotics without checking with a doctor first, a new poll shows
Despite these practices and expectations, 89% of adults aged 50 to 80 who responded to the National Poll on Healthy Aging said they understand that overuse of antibiotics could mean the drugs won’t work against infections in the future. The poll results suggest that millions of doses of antibiotics are currently sitting in the backs of medicine cabinets across the nation.
November 1, 2019
November is National Family Caregivers Month - A time to recognize and honor family caregivers across the country by raising awareness of family caregiver issues. The National Caregivers Action Network provides education tools to support to caregivers as they care for their loved ones.
October 16, 2019
Allied Against Opioid Abuse launched the AAOA-NCL Toolkit in collaboration with the National Consumers League (NCL), to help educate consumers around prescription opioid safety. The AAOA-NCL Consumer Toolkit addresses common questions that patients may have about their rights, risks and responsibilities associated with prescription opioids, and highlights facts about opioid medications to raise awareness about misinformation and prevent misuse before it occurs. BeMedWise is an AAOA partner and NCL is a BeMedWise Supporter.
October 10, 2019
With a new guide to tapering opioids, federal health officials seeks a balanced approach to prescribing
The Health and Human Services Department published new guidance for physicians treating patients that have prescriptions for opioids, recommending that they do not abruptly reduce dosages for people dependent on the drugs to manage chronic pain. Health officials released the guidelines in an attempt to help curb opioid prescriptions overall without harming patients that are using opioid painkillers appropriately, as some experts have raised concern that withholding safe drugs from patients will drive them to the black market.
October 2, 2019
New Source of Information on Preventing Opioid Misuse and Abuse - 34th Talk About Your Medicines Month Addresses Preventing Opioid Misuse and Abuse Across the Ages
Gloucester, MA – The opioid epidemic is a public health emergency. On average, 130 Americans die every day from opioid misuse according to the Centers for Disease Control and Prevention (CDC). All Americans are affected by this problem. It may be the death of a family member from an overdose, the legal problems, or the heartbreak of a friend losing everything due to addiction. This epidemic affects every community. Read more...
September 16, 2019
U.S. physicians are increasingly ordering medications for children for conditions that are not approved by the Food and Drug Administration, according to a Rutgers study. The findings highlight the need for more education, research and policies addressing effective, safe pediatric drug prescribing. Read more...
September 16, 2019
FDA has learned that some ranitidine medicines, including some products commonly known as the brand name Zantac, contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA, a known environmental contaminant and found in water and foods, is considered a probable human cardinogen. Read more...